Ebos GroupASX:EBO +0.97%77 9-Day RSI is 67.11 as of Jul. 06, 2026. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.52 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 124 Medical Distribution companies, Ebos Group ranks worse than 63.71% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-06), Ebos Group's 9-Day RSI is 67.11.
The industry rank for Ebos Group's 9-Day RSI or its related term are showing as below:
ASX:EBO's 9-Day RSI is ranked worse than 63.71% of 124
companies
in the Medical Distribution industry
Industry Median: 53.8
vs ASX:EBO: 67.11
Ebos Group (ASX:EBO) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Ebos Group 9-Day RSI Related Terms
ASX:EBO vs MCK, CAH, COR: 9-Day RSI Comparison
For the Medical Distribution subindustry, Ebos Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group 9-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Ebos Group's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a 9-Day RSI of 67.11 as of Jul. 06, 2026. According to the industry distribution chart, Ebos Group ranks #79 out of 124 companies in the Medical Distribution industry, placing it in the top 63.7%.
Is Ebos Group's 9-Day RSI too high?
Ebos Group's current 9-Day RSI is 67.11. The Medical Distribution industry median 9-Day RSI is 53.80. Ebos Group's value of 67.11 is 24.7% above this industry median. Based on the distribution chart, Ebos Group ranks #79 out of 124 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's 9-Day RSI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #79 out of 124 companies for 9-Day RSI. This places Ebos Group in the lower half of its industry. The industry median 9-Day RSI is 53.80. Ebos Group's value of 67.11 is 24.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Distribution company?
The median 9-Day RSI among Medical Distribution companies is 53.80, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current 9-Day RSI of 67.11 is 24.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median 9-Day RSI is 53.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current 9-Day RSI is 67.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.52, compared to a current price of A$17.64 — trading 44% below its estimated fair value. The current 9-Day RSI is 67.11 and 24.7% above the Medical Distribution industry median of 53.80. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current 9-Day RSI is 67.11 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$17.64 is trading 44% below its estimated GF Value™ of A$31.52.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
9-Day RSI: 67.11
GF Value™: A$31.52 vs. price of A$17.64 (44% below fair value)
Industry Position: 24.7% above the Medical Distribution median (#79 of 124)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 